Skip to content
healthcare.dev

Trijardy XR

NDC 0597-0390, empagliflozin, linagliptin, metformin hydrochloride, tablet, extended release, from Boehringer Ingelheim Pharmaceuticals, Inc..

Product NDC
0597-0390
Status
Listed
Labeler
Boehringer Ingelheim Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212614
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0390 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EMPAGLIFLOZIN25 mg/1
  • LINAGLIPTIN5 mg/1
  • METFORMIN HYDROCHLORIDE1000 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
0597-0390-130059703901390 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-13)
0597-0390-710059703907130 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-71)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/71873567-9594-452a-bb92-34a129adecac
  • NADAC price for package 00597039013

    GET /v1/drugs/nadac/00597039013
  • NADAC price for package 00597039071

    GET /v1/drugs/nadac/00597039071

Use it

Look up 0597-0390 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0390 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0597-0390. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.